Overwhelmed by the anticipated harms of COVID-19, we must remember that other diseases will continue to progress during the pandemic. With all our patients, we will have to ask ourselves a new question: What is the best approach to treating their disease, and how does our fear of COVID-19 affect our shared risk–benefit calculus? Read about one provider’s perspective from the New England Journal of Medicine.
https://www.nejm.org/doi/full/10.1056/NEJMp2006607?query=TOC